Actelion Ltd. Wins Investor Support As Fight Intensifies
WSJ -- ZURICH (Dow Jones)--One of Actelion Ltd's (ATLN.VX) largest investors Monday voiced support for the embattled Swiss biotech firm, which has come under pressure from a large investor to review its strategy, reshuffle its board and potentially consider selling itself.